Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling Endo USA, Inc. is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.

Watch out for this, mislabeling of #clonazepam

#mentalhealth #benzodiaepines #psychiatry #medication #recall

www.fda.gov/safety/recal...